PSMA PET/CT Versus mpMRI for the Detection of Clinically Significant Prostate Cancer: An Updated Overview

M Caracciolo, A Castello, E Lopci - Seminars in Nuclear Medicine, 2023 - Elsevier
In the last years, PSMA-PET imaging and multiparametric MRI (mpMRI) have improved the
clinical management of prostate cancer (PCa) patients. Currently, mpMRI is recommended …

[HTML][HTML] Prostate-specific membrane antigen-targeted surgery in prostate cancer: Accurate identification, real-time diagnosis, and precise resection

J Jiao, J Zhang, W Wen, W Qin, X Chen - Theranostics, 2024 - ncbi.nlm.nih.gov
Radical prostatectomy (RP) combined with pelvic lymph node dissection (PLND) is the first
step in multimodal treatment of prostate cancer (PCa) without distant metastases. For a long …

Prostate cancer presentation and management in the Middle East

M Sayan, A Langoe, O Aynaci, AA Eren, MF Eren… - BMC urology, 2024 - Springer
Background Although prostate cancer is a prevalent malignancy worldwide, its clinical
presentation and management in the Middle East are not well-documented. This study aims …

A Systematic Review on Prostate-Specific Membrane Antigen Positron Emission Tomography (PSMA PET) Evaluating Localized Low-to Intermediate-Risk Prostate …

J Liu, J Santucci, DTS Woon, R Catterwell, M Perera… - Life, 2024 - mdpi.com
Active surveillance remains a treatment option for low-to intermediate-risk prostate cancer
(PCa) patients. Prostate-specific membrane antigen positron emission tomography and …

Impact of PSMA PET on Prostate Cancer Management

AB Weiner, R Agrawal, LF Valle, I Sonni… - … Treatment Options in …, 2024 - Springer
PSMA-PET has been a practice-changing imaging biomarker for the management of men
with PCa. Research suggests improved accuracy over conventional imaging and other PET …

Risk factor analysis and optimal cutoff value selection of PSAD for diagnosing clinically significant prostate cancer in patients with negative mpMRI: results from a high …

S Lin, W Jiang, J Ding, S Hao, H Chen, L Xie… - World Journal of …, 2024 - Springer
Background Multi-parametric magnetic resonance imaging (mpMRI) is a diagnostic tool
used for screening, localizing, and staging prostate cancer. Patients with Prostate Imaging …

Current role of PSMA-PET imaging in the clinical management of prostate cancer

A Georgakopoulos, A Bamias… - … Advances in Medical …, 2023 - journals.sagepub.com
Despite the developments of the last few years, metastatic castration-resistant prostate
cancer (PC) remains a deadly disease. Until recently, almost all guidelines recommended …

68Ga-PSMA-11 PET/CT versus mpMRI in the Detection of Primary Prostate Cancer: A Systematic Review and Head-to-Head Comparative Meta-Analysis

X Ren, MNS Yusoff, NHM Taib, L Zhang… - European Journal of …, 2023 - Elsevier
Purpose The goal of this study was to evaluate the effectiveness of two diagnostic methods,
68 Ga-PSMA-11 PET/CT and mpMRI, in detecting primary prostate cancer without limitations …

Salvage Radiotherapy PSMA PET/CT-guided in Men With PSA Recurrence

M Tamburo, E Buffettino, P Pepe, G Marletta… - Anticancer …, 2024 - ar.iiarjournals.org
Background/Aim: To evaluate the clinical outcome in men with recurrent prostate cancer
(PCa) treated by salvage radiotherapy (sRT) prostate-specific membrane antigen positron …

68Ga-prostate specific membrane antigen-11 PET/CT versus multiparametric MRI in the detection of primary prostate cancer: A systematic review and head-to-head …

X Ren, MNS Yusoff, NHM Taib, L Zhang… - European Journal of …, 2024 - ejradiology.com
Purpose The goal of this study was to evaluate the effectiveness of two diagnostic methods,
68 Ga-PSMA-11 PET/CT and mpMRI, in detecting primary prostate cancer without limitations …